NCR is currently open. We have taken steps to keep our staff and our patients safe during their office visit. We are practicing social distancing, wearing masks, vigorously cleaning, and washing hands before and after every patient visit. We ask for each patient to also wash their hands on arrival prior to signing in. should you have a temperature over 100 degrees or have been with someone who does, please do not come to the office; we will reschedule you as soon as we can. If you have traveled to one of the hot spots in the country in the past 7 days, please do not come to the office; we will reschedule you after a 7 day break. Thank you for helping keep everyone safe.
Visit The Alzheimer's Research Center Website

Varicella Vaccine

by | Feb 4, 2021 | Enrolling Studies, Pediatric Studies | 0 comments

Brief Summary:

Varicella (i.e., chickenpox) is caused by the highly contagious varicella zoster virus, which typically affects children under 10 years of age. It is characterized by fever and skin rash with small, fluid-filled blisters. Chickenpox is commonly regarded as a mild childhood illness. However, serious complications can occur, leading to hospitalizations and in rare cases even to death.  Doctors at National Clinical Research are researching a new investigational varicella vaccine that that is similar to the one currently on the market.

The CDC recommends children receive routine vaccinations for varicella, measles, mumps, and rubella (MMR), hepatitis A virus (HAV), and pneumococcal conjugate (PCV) at 12 to 15 months of age.  If you child participates in this study, they will receive approved marketed vaccines for MMR, HAV, PCV and either Varivax or the investigational varicella vaccine. Varivax is currently the only vaccine available for chicken pox.  This study which we will be conducting is designed to determine if the investigational varicella vaccine produces the same protection as the one currently on the market.

Age:

12 – 15 months of age

Key Inclusion / Exclusion Criteria:
  • Immunosuppressive or immunodeficient condition
  • Hypersensitivity to latex
  • History of chicken pox
Patient Commitment Duration:

1 office visit; 2 phone calls in 6 months

Patient Compensation:

You may be reimbursed up to $637 for your participation.

Want to participate? Fill out the interest form! Click to Call Us!